ArticleTranslational lung cancer research2024

Triple-targeted therapy of dabrafenib, trametinib, and osimertinib for the treatment of the acquired

Cheng-Di Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.